Typhoid Vaccine Wyeth - Biotech, Pharma and Life Science Channel

04:20 EDT 2nd August 2015 | BioPortfolio

PubMed Articles [1710 Associated PubMed Articles listed on BioPortfolio]

Fabrication of chitosan microspheres using vanillin/TPP dual crosslinkers for protein antigens encapsulation.

Microspheres were prepared from water soluble chitosan using dual vanillin/TPP crosslinkers. Placebo (C1), Bovine serum albumin (BSA) (C2), monovalent tetanus toxoid (TT) (C3) and divalent tetanus (TT...

Chimeric DNA vaccines encoding Eimeria acervulina macrophage migration inhibitory factor (E.MIF) induce partial protection against experimental Eimeria infection.

Chimeric DNA vaccines co-expressing Eimeria acervulina macrophage migration inhibitory factor (E.MIF) and chicken IL-2 (IL-2) or interferon-γ (IFN-γ) were constructed and their efficacies against E....

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.

The vaccination rate against hepatitis B virus (HBV) is low in inflammatory bowel disease (IBD) patients. The Consensus from the European Crohn's and Colitis Organisation on opportunistic infections r...

Advances in development of a contraceptive vaccine against human chorionic gonadotropin.

There is continuing need for contraceptives. According to World Health Organization, 210 million pregnancies occur each year, out of which some 80 million are unintended. A vaccine offering privacy an...

107 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.

EGFRvIII, a constitutively active EGFR deletion driver mutation, is associated with poor long-term survival in glioblastoma (GB). The investigational vaccine rindopepimut consists of a peptide sequenc...

Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger.

To inform epidemic response strategies for the African meningitis belt after a meningococcal serogroup A conjugate vaccine was introduced in 2010, we compared the effectiveness and efficiency of menin...

Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs.

Following the recognition of a measles case in a hospital in The Netherlands, health care workers (HCW) from the premises were screened by a commercial enzyme immunoassay (EIA) for measles IgG to iden...

MMR Vaccine Doesn't Increase Autism Spectrum Disorder Risk.

According to this study.

Vaccine Safety Resources for Nurses.

The CDC supports nurses in promoting vaccination.

Vaccine Fear Derails Triumph Over Disease.

Let's not take our public health gains for granted.

News Articles [2285 Associated News Articles listed on BioPortfolio]

Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech

Garretson, SD, August 01, 2015 --(PR.com)-- Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was ...

Novavax Announces Positive Phase 2 Results For Its Seasonal Influenza Vaccine

(BiotechPickList) – On July 30, 2015 Novavax (NASDAQ:NVAX) announced positive phase 2 results for its seasonal influenza vaccine that uses the company’s VLP platform. The VLP platform stan...

Effective ebola vaccine may be here: health officials

(HealthDay)—An experimental Ebola vaccine appears highly effective against the deadly infectious disease, according to an interim analysis of findings from a clinical trial being conducted in the We...

Where speed matters: GMO Ebola vaccination to save lives

A sample of publications describing the new Ebola vaccine success:Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of&nb...

WHO Says Ebola Vaccine Possibly Effective in Trial

European researchers said an experimental Ebola vaccine tested in Guinea “might be effective” in protecting people from the deadly virus, but questions have been raised about the way the study was...

Experimental Ebola vaccine could stop virus in West Africa

Read more about Experimental Ebola vaccine could stop virus in West AfricaComments

Ebola Vaccine Success: AHF Says, “World Must Proceed in All Due Haste and With All Financial Resources Necessary”

The Guardian newspaper reports today that an Ebola vaccine trial in Guinea was shown to be 100% effective in a trial involving 4,000 people, noting that, “The results of the tri...

Merck's Ebola Vaccine Found 100% Effective In Guinea Trial

WHITEHOUSE STATION (dpa-AFX) - Drugmaker Merck & Co. Inc. (MRK) said Friday that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim ...

The Lancet publishes interim Phase III Ebola vaccine data

Single doses of Ebola vaccine rVSV-EBOV (VSV-ZEBOV;VSV-EBOV) showed 100% efficacy in an interim analysis of an open-label Guinean Phase III trial. Data from the World Health Organization (WHO)-sponsor...

Merck/NewLink Ebola vaccine 100% effective in Guinea trial

Early results of an experimental Ebola vaccine being developed by Merck and its partner NewLink which licensed the product from the Canadian government, showed the candidate, known as rVSV-ZEBOV, was ...

Events [0 Results]

None

Companies [90 Associated Companies listed on BioPortfolio]

Aduro BioTech, Inc.

Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of at...

The Vaccine & Gene Therapy Institute of Florida (VGTI Florida)

Targovax

Targovax was started in October 2010 to develop TG01, a vaccine targeting pancreatic cancer. TG01 is based on research from The Radium Hospital and Norsk Hydro in the end of the 9...

Genocea Biosciences

Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Company’s proprietary T cell-directed antigen disc...

The Vaccine & Gene Therapy Institute of Florida

ImmusanT Inc.

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challengi...

Mucosis B.V.

Mucosis B.V. (Mucosis) is a clinical-stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious disea...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied fo...

Clinical Trials [2276 Associated Clinical Trials listed on BioPortfolio]

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun®

FSME-Immun® is registered for application into the muscle. This study investigates if application under the skin leads to a comparable immune response.

TBE Vaccination in Allergic Patients

Allergic patients especially those undergoing de-sensitization treatment have an altered immune responsiveness. The investigators aim to find out whether this influences immune responses t...

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

The early clinical development paradigm for chemotherapeutic agents has significantly influenced the development of therapeutic cancer vaccines. However, there are major differences betwee...

A Pilot Study Comparing the Effectiveness of Campus Intervention to Increase HPV Vaccine Rate Among College Aged Men

This is a study testing what type of message and access influences a young male to get the HPV vaccine. The investigators are conducting a 2 X 2 design These conditions are: ...

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects

Study AFF011 is a single blind, single-center, randomized, placebo-controlled, parallel group, phase I clinical trial of repeated administration by subcutaneous injection of a single dose ...

A Study to Evaluate the Efficacy of MEDI7510 in Older Adults

This study will be the first assessment of the efficacy of MEDI7510 for the prevention of RSV disease. It will also provide estimates of vaccine efficacy and of endpoint incidence in the p...

Multi-peptide CMV-MVA Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

This randomized phase II trial studies the safety and how well multi-peptide cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) vaccine works in reducing CMV complications in patients pr...

Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy

Background and aims: Nucleos(t)ide analogues may suppress HBV DNA to undetectable level, but only about 30-40% remain sustained response 1-3 years after discontinued therapy. The investiga...

Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic

Tuberculosis (TB) is a global challenge and for the increasing epidemic of multi-drug resistant (MDR)-TB there is restricted treatment options. This calls for research of new immune-modula...

Speed of Injection and Pain During Routine Infant Vaccinations

Vaccine injections are a significant source of pain for infants. Altering the injection speed when administering vaccines may be an effective intervention and is feasible (cost neutral). A...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.


Advertisement
 
Advertisement
 
review and buy Typhoid Vaccine Wyeth market research data and corporate reports here

Channels Quicklinks